Outpatient Chimeric Antigen Receptor T cell Therapy in Patients Who Resided at Their Home Compared to Hospital-Provided Housing: A Single Institution Experience
Key Points
Outpatient chimeric antigen receptor T cell therapy shows promising outcomes compared to hospital housing.
Key metrics indicate that patients treated at home experienced a 20% higher satisfaction rate.
Assessment using an observational analysis at a single institution highlighted differences in patient recovery.
Findings may inform future treatment models, advocating for outpatient approaches to enhance patient well-being.
Outpatient Chimeric Antigen Receptor T cell Therapy in Patients Who Resided at Their Home Compared to Hospital-Provided Housing: A Single Institution Experience | Synapse